The Grants Review and Awards Committee
Dr. Jennifer Arnold, MBBS (hons), FRANZCO (Chair)
Dr. Arnold is a partner at Marsden Eye Specialists in New South Wales, Australia. She specialises in retinal and macular diseases, as well as cataract and all aspects of general ophthalmology.
As well as performing clinical duties, Dr. Arnold co-ordinates a research team of ophthalmologists, orthoptists and registered nurses that conducts numerous ongoing international and local clinical trials. Her main research focus is the development of new treatments for age-related macular degeneration (AMD), diabetic macular edema, and retinal vein occlusion. Indeed, Dr. Arnold was involved in the revolutionary work carried out in recent years to improve the diagnosis and management of AMD.
Dr. Arnold has numerous publications and is a member of the Macula Society. In 2012 she became the Chair of the Grants Review and Awards Committee for the Bayer Global Ophthalmology Awards Program.
Professor Quan Dong Nguyen, MD, MSc (Co-Chair)
Born in Saigon, Vietnam, and immigrated with his parents and three brothers to the United States in 1980, Professor Quan Dong Nguyen currently holds the McGaw Endowed Chair in Ophthalmology and is Professor and Chairman of the Department of Ophthalmology and the Inaugural Director of the Stanley M. Truhlsen Eye Institute at the University of Nebraska Medical Centre. Prior to being chosen for the chairmanship at Nebraska, Professor Nguyen was on the faculty at the Wilmer Eye Institute, Johns Hopkins University School of Medicine in Baltimore, Maryland.
Professor Nguyen received his baccalaureate from the Phillips Exeter Academy in Exeter, New Hampshire and his bachelor and master of science degrees simultaneously in molecular biophysics and biochemistry from Yale University in New Haven, Connecticut. Subsequently, he earned his medical degree at the University of Pennsylvania School of Medicine in Philadelphia. He completed an internship in internal medicine at the Massachusetts General Hospital and a residency in ophthalmology at the Massachusetts Eye and Ear Infirmary, Harvard Medical School in Boston. Professor Nguyen also completed fellowships in immunology and uveitis at the Massachusetts Eye and Ear Infirmary, ocular immunology at the Wilmer Eye Institute of the Johns Hopkins Medical Institutions, and medical and surgical diseases of the vitreous and retina at the Schepens Eye Research Institute and the Massachusetts Eye and Ear Infirmary.
A diplomate of the American Board of Ophthalmology and a Fellow of the American Academy of Ophthalmology, Professor Nguyen has received many commendations and awards, including the National Institutes of Health National Research Service Award; the Charles L. Schepens, MD, Award for Excellence in Retina Research; the National Eye Institute Career Development Award; the National Eye Institute/National Institutes of Heath RO1 and R24 Awards; the Foundation Fighting Blindness Research Award for Macular Degeneration; the Juvenile Diabetes Research Foundation Innovative Award; the American Academy of Ophthalmology Achievement Award; the American Society of Retina Specialists Senior Honor Award; the Research to Prevent Blindness Physician Scientist Award; and the Carl Camras Translational Research Award from the Association for Research in Vision and Ophthalmology.
Professor Nguyen serves as principal investigator on several clinical trials sponsored by the National Eye Institute and other organisations for macular edema (from diabetes and uveitis), neovascular age-related macular degeneration (AMD), and ocular inflammatory and uveitic diseases, as well as co-investigator on numerous other clinical trials involving novel therapeutic agents. Professor Nguyen chairs the United States multi-centre READ-2 and READ-3 studies, evaluating the potential role of VEGF antagonists for diabetic macular edema. He is also leading the SAVE, SAVE-2, and STOP-UVEITIS studies to evaluate the role of new pharmacologic agents in uveitis and ocular inflammatory diseases.
Professor Nguyen has been elected to many prestigious national and international professional organisations, including the American Academy of Ophthalmology, the Macula Society, the Retina Society, the American Society of Retina Specialists, the American Uveitis Society, the International Ocular Inflammation Society, and the Association for Research in Vision and Ophthalmology. At the Johns Hopkins School of Medicine, Professor Nguyen served on the Admissions Committee, the Educational Policy and Curriculum Committee, and the Student Assessment and Program Evaluation Committee, among others. Professor Nguyen was also the Director of Medical Student Education in Ophthalmology at Johns Hopkins.
Professor Nguyen has been very active in Vietnamese medical professional organisations since 1992 when he was still a medical student. In 2004, Professor Nguyen became the first US medical school graduate to lead the Vietnamese American Medical Association (VAMA) as President; Professor Nguyen was re-elected as President of the VAMA in 2007 and served until 2010. Professor Nguyen also served as President of the Vietnamese Medical Association of the Free World from 2005 to 2008.
Professor Nguyen has also been very involved in helping to enhance and promote activities of the International Ocular Inflammation Society. Most recently, Professor Nguyen co-chaired the Scientific Program Committee for the 2011 IOIS Congress in Goa and has been elected to serve on the 2012-2014 IOIS Executive Committee.
Professor Francesco Bandello, MD, FEBO
Prof. Bandello is Full Professor and Chairman at the Department of Ophthalmology at University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy. Prof. Bandello is President of EURETINA, President of Academia Ophthalmologica Europea and Vice-President of EuroLam.
Prof. Bandello is Co-Editor of the European Journal of Ophthalmology and former board member of both the Club Jules Gonin and the Macula Society. He is a member of the Executive Board of the ESASO Foundation (European School for Advanced Studies in Ophthalmology), the Academia Ophthalmologica Internationalis and the Accademia Nazionale di Medicina. Prof. Bandello has co-authored 9 books and he serves as a peer reviewer for grant applications for the NEI. He has authored or co-authored 274 articles and he served as the principal investigator in several multicenter clinical trials mainly concerning retinal diseases.
Dr. Patricia A. D’Amore, PhD, MBA, FARVO
Dr. D’Amore is The Charles L. Schepens Professor of Ophthalmology, Professor of Pathology, and Vice-Chair of Basic Research at Harvard Medical School; she is Director of Research, Senior Scientist and Ankeny Scholar of Retinal and Molecular Biology at the Schepens Eye Research Institute at Massachusetts Eye and Ear Infirmary; and Director of the Howe Laboratory and Associate Chief of Basic and Translational Research at Massachusetts Eye and Ear Infirmary, Boston, USA. Further, she is a research associate in surgery at Boston Children’s Hospital. Her research focuses on understanding the mechanism of vascular growth, development and pathology, and pericyte–endothelial cell interactions.
After receiving a BA from Regis College in Weston, Massachusetts, in 1973, Dr. D’Amore obtained a PhD in biology from Boston University in 1977, followed by a postdoctoral fellowship in biological chemistry and ophthalmology at Johns Hopkins University School of Medicine, Baltimore, MD in 1979. She then received an MBA in finance in 1987 from Northeastern University, Boston, and was selected as a fellow of the Association for Research in Vision and Ophthalmology (FARVO) in 2009.
Dr. D’Amore has over 200 publications to her credit, some of which have appeared in journals such as Nature Medicine, Journal of Clinical Investigation, Development and the Journal of Cell Biology. In addition to her scientific achievements, Dr. D’Amore has won numerous awards for her role as a mentor and teacher, having trained over 70 undergraduate and graduate students, research assistants, and postdoctoral fellows.
Mr Philip Hykin, MD, FRCS, FRCO
Mr Philip Hykin was appointed Consultant Ophthalmologist to the Medical Retina Service at Moorfields Eye Hospital in 1996 and was Director of the Medical Retina Service from 2003 to 2008. His training in retinal ophthalmology began at Moorfields and, following a period of research in The Institute of Ophthalmology, he completed a Fellowship at Wills Eye Hospital, Philadelphia, USA. He currently holds medical retina clinics, concentrating on patients with retinovascular disease and AMD. Special interests include the pathogenesis of diabetic macular oedema and idiopathic polypoidal choroidal vasculopathy, and new therapies for diabetic maculopathy and wet AMD (wet AMD).
Mr Philip Hykin has given numerous invited lectures in the UK and abroad, and is a member of ARVO, the American Academy of Ophthalmology, and the Macula Society. He has over 70 publications in peer-reviewed journals and has contributed to numerous book chapters. He was UK Chief Investigator for trials of sodium pegaptanib and other anti-VEGF agents in wet AMD, and Principal Investigator for trials of ruboxistaurin in diabetic macular oedema, posurdex in central and branch retinal vein occlusion, intravitreal triamcinolone in diabetic macular oedema, and bevacizumab in diabetic maculopathy. An ongoing project includes the use of novel adaptive optics high-resolution imaging systems in AMD.
Dr Peter J. Kertes, MD, CM, FRCSC
Dr. Kertes majored in molecular biology at Princeton University, NJ, USA, as an undergraduate and went to McGill University, Montreal, Canada, for Medical School. He then did a residency in ophthalmology at the University of Ottawa, Ontario, Canada, and undertook a 2 year vitreo-retinal surgical fellowship with Dr. Gholam Peyman at Louisiana State University in New Orleans, USA.
He was in practice in Ottawa from 1997 and moved to Toronto and the Sunnybrook Health Sciences Centre,in 2003 and is currently a vitreoretinal surgeon and the Ophthalmologist-in-chief of the John and Liz Tory Eye Centre at Sunnybrook, and on staff at the Hospital for Sick Children. He is also a professor of ophthalmology and vision sciences at the University of Toronto.
Dr. Kertes has an interest in clinical epidemiology and evidence-based medicine and has published three books on the major clinical trials in ophthalmology, which are a staple of every resident’s library. He served as one of the editors-in-chief of the journal, Evidence-based Ophthalmology, he has authored many textbook chapters, and more than 60 peer-reviewed publications.
Dr. Kertes has a special interest in international ophthalmology and has participated in 20 volunteer projects throughout the developing world, many of them focused on retinopathy of prematurity and pediatric retina.
Dr. William Li, MD
Dr Li received his AB with honours in Biochemistry from Harvard College, and his MD from the University of Pittsburgh School of Medicine, Pennsylvania. He completed his residency training and clinical fellowship in General Internal Medicine at the Massachusetts General Hospital in Boston. Dr William Li is President, Medical Director, and co-founder of the Angiogenesis Foundation, a non-profit organisation that is re-conceptualising global disease fighting.
A protégé of medical pioneer Dr Judah Folkman, Dr Li has been engaged in research focused on angiogenesis and its practical applications in ophthalmology, cancer, wound and tissue repair, cardiovascular diseases, and other pathologies. A major part of Dr Li’s work focuses on translating science to practical interventions that improve health outcomes for individuals and populations using angiogenesis-based therapies. Dr Li has testified before congressional and other governmental audiences on the impact of angiogenesis in healthcare, and he works internationally with medical, scientific, bio-pharmaceutical, device, payer, and health policy audiences. His non-profit work has been cited by The New York Times, Fortune, and CNN; he has also been a speaker at the TED Conference, and is a member of the Clinton Global Initiative.
Dr Li has served on faculties at the Harvard Medical School, Tufts University, and Dartmouth Medical School. He has numerous papers in Science, The New England Journal of Medicine, The Lancet, and other leading peer-reviewed medical journals.
Professor Pascale Massin, MD, PhD
Prof. Massin is the Head of the Ophthalmology Department at Lariboisière Hospital in Paris, France, and has a PhD in screening for diabetic retinopathy as well as a degree of Specialised Studies in Health and Society.
Prof. Massin is a leading international specialist in surgical and medical management for all retinal affections, particularly management of diabetic eye complications. She specialises in retinovitreal surgery, complex cases of diabetic retinopathy, retinal detachment, and macular surgery. Her work includes patient management of medical affections of the retina, including retinal vasculopathy, AMD, and rare pathologies of the fundus in the CERVCO framework (Reference Centre for Rare Vascular Diseases of the Brain and the Eye).
Prof. Massin has been the International Coordinator and Principal Investigator for many industrial trials of medicines used widely in ophthalmology today. She has received numerous awards for her work, including the prize for the Public Sector Manager of the Year in the Category of Healthcare Establishments for the OPHDIAT network, a network for the diagnosis of diabetic retinopathy by teletransmission of eye fundus images. She also teaches medical school and postgraduate science students, and has directed many theses for the title of Doctor of Medicine and Master in Sciences; in addition, she conducts teaching seminars for practising ophthalmologists.
Prof. Massin has published widely; this includes articles in English and French reviews with a reading committee, and book chapters dealing with retinal disorders and diabetic retinopathy.
Prof. Massin is a Knight of the Legion of Honor of the French Republic.
Prof. Masahito Ohji, MD
Prof. Ohji is Chairman of the Department of Ophthalmology at Shiga University of Medical Science in Otsu, Japan. He graduated from Osaka University Medical School in 1983, and had become Assistant Professor of the Department of Ophthalmology by 1993. Prof. Ohji is on the editorial board for a range of journals, including the Journal of Japanese Ophthalmological Society and is Co-editor of Graefe's Archive for Clinical and Experimental Ophthalmology. He is also a Committee Member of both the Japanese Retina and Vitreous Society and the Japanese Society for Ocular Circulation, and is a Scientific Advisor for the AMD (age-related macular degeneration) Alliance International.
Prof. Ohji has produced more than 150 scientific publications, and has co-authored many chapters in ophthalmology textbooks. His research interests include retinal and vitreous biology.
Professor Calvin C. P. Pang, DPhil
Prof. Pang is S.H. Ho Professor of Visual Sciences, Professor of Ophthalmology and Visual Sciences and Chairman of the Department of Ophthalmology and Visual Sciences at The Chinese University of Hong Kong, China. He is also Director of The Shantou University / The Chinese University of Hong Kong Joint Shantou International Eye Centre. His research interests include genomic studies and gene mapping of glaucoma, retinal diseases, myopia and congenital cataracts, as well as molecular genetics and epigenetics of retinoblastoma, thyroid-associated orbitopathy, diabetic retinopathy, retinitis pigmentosa, uveitis, corneal dystrophies, and hereditary optical neuropathies. He also works on ocular stem cells and herbal molecules and their effects in eye diseases.
Prof. Pang received a BSc in Biochemistry in 1978 from the University of London, UK. He then completed a DPhil research program at the University of Oxford on an EP Abraham Research Fund Scholarship, followed by two years’ postdoctoral research in Oxford. Prof. Pang has produced more than 340 papers in international peer-reviewed journals and 13 book chapters. He is a reviewer for the Wellcome Trust (UK), National Eye Institute (USA), National Medical Research Council (Singapore), Health Research Board (Ireland), Catalan Agency for Health Technology Assessment and Research (Spain) and National Natural Science Foundation of China. He is an advisor, honorary or visiting professor of more than 20 clinical or research institutions and has numerous academic duties in mainland China.
Professor Daniel Pauleikhoff, MD
Prof. Pauleikhoff was awarded his Medical Degree from the University of Münster in 1983, and became a research associate at the Department of Ophthalmology at the University of Essen, Germany. He then specialised in retinal diseases and completed his residency in 1988. Afterwards he started an 18-month fellowship in medical retina with Prof. A.C. Bird and J. Marshall at the Institute of Ophthalmology/Moorfields Eye Hospital, London, UK.
After his return to the University of Essen in 1989, Prof. Pauleikhoff was appointed Senior Physician in the Department for Posterior Segment Disease. In 1993 he was appointed Senior Consultant of Ophthalmology at the Department of Ophthalmology, St. Franziskus Hospital Münster and continued as Professor of Ophthalmology at the University of Essen; positions that he continues to hold today.. In 2010, he was awarded a further honorary professorship at Moorfields Eye Hospital.
Prof. Pauleikhoff’s main research activities focus on pathogenesis, phenotyping and therapy of age-related macular degeneration (AMD). He is principal investigator for various interventional clinical trials in AMD, diabetic retinopathy and retinal vein occlusions and has received many scientific grants for basic science and clinical investigations. He serves on the editorial boards of several scientific ophthalmological journals and is an elected board member of the German Ophthalmological Society. He has been elected President of the German Retina Society for the period 2012–2016, having served on the board of this society as a vice-president for the previous 4 years. Prof. Pauleikhoff has authored over 150 publications in peer-reviewed journals, he is editor/co-editor on several books on macular diseases and has delivered several honorary lectures.
Dr. Francisco Rodríguez, MD
Dr. Rodríguez is the Scientific Director of the Fundación Oftalmológica Nacional and Chairman of the department of ophthalmology at Universidad del Rosario School of Medicine in Bogotá, Colombia. He received his medical degree from the Universidad del Rosario School of Medicine in 1986, and carried out his ophthalmology residency at the Fundación Oftalmológica Nacional in Bogotá. Dr. Rodríguez then completed a vitreoretinal surgical fellowship at the Jules Stein Eye Institute (University of California), Los Angeles, a medical retina fellowship at the Manhattan Eye, Ear and Throat Hospital, New York, and an electrophysiology/hereditary retinal diseases fellowship at Bascom Palmer Eye Institute (University of Miami School of Medicine), USA.
Dr. Rodríguez has participated as Principal Investigator in clinical trials, and he has received several awards, including the National Academy of Medicine award in 1997. He has produced more than 75 publications in national and international peer-reviewed journals and has also authored several chapters in retina textbooks. His research interests include diabetic retinopathy, AMD, inflammatory diseases of the retina and choroid, retinal vascular diseases, retina imaging and macular surgery.
Professor Tien Yin Wong, MD, PhD
Prof. Wong is the Provost’s Chair Professor, and Medical Director at the Singapore National Eye Center; Vice-Dean of the Office of Clinical Sciences at Duke-NUS Medical School, National University of Singapore Group; and Director of Research for Singapore Health Services.
Prof. Wong completed medical school at the National University of Singapore (NUS) as a President’s scholar, then carried out his residency training in ophthalmology at the Singapore National Eye Centre (SNEC), and retinal fellowships at the University of Wisconsin, Madison, USA and University of Sydney, Australia. He has an MPH (Master of Public Health) and PhD from the Johns Hopkins University, Baltimore, MD, USA.
As Medical Director of SNEC, Prof. Wong helms one of the largest tertiary eye hospitals in Asia, with a faculty of more than 70 ophthalmologists managing 300,000 outpatient visits and 15,000 major surgeries annually. The research division of SNEC, the Singapore Eye Research Institute (SERI), is one of the world’s leading eye research institutes. In his dual role as Vice-Dean of the Office of Clinical Sciences at Duke-NUS Graduate Medical School, and Director of Research for SingHealth (Singapore Health Services), he coordinates clinical and translational research strategy and execution across the SingHealth-Duke-NUS academic medicine cluster. Prior to his current appointments, Prof. Wong was Executive Director of SERI, Chairman of the Department of Ophthalmology at the National University of Singapore, and Chairman of the Department of Ophthalmology at the Royal Victorian Eye and Ear Hospital, Melbourne, Australia.
Prof. Wong balances clinical practice in ophthalmology, focusing on retinal diseases such as diabetic retinopathy and age-related macular degeneration, with a broad-based research program comprising epidemiological, clinical and translational studies of Asian retinal diseases, and on the use of retinal imaging to predict disease risk. He has published more than 900 peer-reviewed papers, in international journals including the New England Journal of Medicine and The Lancet. He has given over 200 invited plenary, symposium and named lectures globally, and received more than US$50 million in grant funding as a principal investigator.
For his service and research, Prof. Wong has been recognized nationally and internationally with numerous awards, such as the Sandra Doherty Award from the American Heart Association, the Alcon Research Institute Award, the Novartis Prize in Diabetes, the Commonwealth Health Minister’s Award, and the Arnall Patz Medal from the Macula Society. He has been recognized with the Outstanding Researcher Award from the National University of Singapore on two occasions (2004 and 2009) and has received the National Clinician Scientist Award and the President’s Science Award, two of the highest awards in Singapore.